SEARCH

SEARCH BY CITATION

References

  • 1
    Cheesman S, Raza A & Carter R. Mixed strain infections and strain-specific protective immunity in the rodent malaria parasite Plasmodium chabaudi chabaudi in mice. Infect Immun 2006; 74: 29963001.
  • 2
    Eisen DP, Saul A, Fryauff DJ, Reeder JC & Coppel RL. Alterations in Plasmodium falciparum genotypes during sequential infections suggest the presence of strain-specific immunity. Am J Trop Med Hyg 2002; 67: 816.
  • 3
    Cheesman S, O’Mahony E, Pattaradilokrat S, Degnan K, Knott S & Carter R. A single parasite gene determines strain-specific protective immunity against malaria: the role of the merozoite surface protein I. Int J Parasitol 2010; 40: 951961.
  • 4
    Nussenzweig RS, Vanderberg J, Most H & Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 1967; 216: 160162.
  • 5
    VanBuskirk KM, O’Neill MT, De La Vega P, et al. Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci USA 2009; 106: 1300413009.
  • 6
    Purcell LA, Yanow SK, Lee M, Spithill TW & Rodriguez A. Chemical attenuation of Plasmodium berghei sporozoites induces sterile immunity in mice. Infect Immun 2008; 76: 11931199.
  • 7
    Roestenberg M, McCall M, Hopman J, et al. Protection against a malaria challenge by sporozoite inoculation. N Eng J Med 2009; 361: 468477.
  • 8
    Purcell LA, Wong KA, Yanow SK, Lee M, Spithill TW & Rodriguez A. Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge. Vaccine 2008; 26: 48804884.
  • 9
    Sedegah M, Weiss WW & Hoffman SL. Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites. Parasite Immunol 2007; 29: 559565.
  • 10
    Douradinha B, Van Dijk MR, Ataide R, et al. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. Int J Parasitol 2007; 37: 15111519.
  • 11
    Hoffman SL, Goh LM, Luke TC, et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 2002; 185: 11551164.
  • 12
    Collins WE & Jeffery GM. A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum in patients previously infected with heterologous species of Plasmodium: effect on development of parasitologic and clinical immunity. Am J Trop Med Hyg 1999; 61: 3643.
  • 13
    Sina BJ, Do Rosario VE, Woollett G, Sakhuja K & Hollingdale MR. Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection. Exp Parasitol 1993; 77: 129135.
  • 14
    Sacci JB Jr, Schriefer ME, Resau JH, et al. Mouse model for exoerythrocytic stages of Plasmodium falciparum malaria parasite. Proc Natl Acad Sci USA 1992; 89: 37013705.
  • 15
    Nussenzweig RS, Vanderberg JP, Most H & Orton C. Specificity of protective immunity produced by x-irradiated Plasmodium berghei sporozoites. Nature 1969; 222: 488489.
  • 16
    Kawabata Y, Udono H, Honma K, et al. Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii. Infect Immun 2002; 70: 60756082.
  • 17
    Landau I & Boulard Y. Rodent Malaria. Killick-KendrickR & PetersW (eds). London, New York, San Francisco, Academic Press, 1978: 5384.
  • 18
    Doolan DL & Hoffman SL. The complexity of protective immunity against liver-stage malaria. J Immunol 2000; 165: 14531462.
  • 19
    Doolan DL & Hoffman SL. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. J Immunol 1999; 163: 884892.
  • 20
    Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R & Nussenzweig V. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 1987; 330: 664666.
  • 21
    Weiss WR, Sedegah M, Berzofsky JA & Hoffman SL. The role of CD4+ T cells in immunity to malaria sporozoites. J Immunol 1993; 151: 26902698.
  • 22
    Belnoue E, Costa FT, Frankenberg T, et al. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 2004; 172: 24872495.
  • 23
    Butler NS, Schmidt NW & Harty JT. Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites. J Immunol 2010; 184: 25282538.
  • 24
    Pattaradilokrat S, Cheesman SJ & Carter R. Linkage group selection: towards identifying genes controlling strain specific protective immunity in malaria. PLoS ONE 2007; 2: e857.
  • 25
    Cheesman S, Tanabe K, Sawai H, O’Mahony E & Carter R. Strain-specific immunity may drive adaptive polymorphism in the merozoite surface protein 1 of the rodent malaria parasite Plasmodium chabaudi. Infect Genet Evol 2009; 9: 248255.
  • 26
    Kumar S, Miller LH, Quakyi IA, et al. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature 1988; 334: 258260.
  • 27
    Zavala F, Cochrane AH, Nardin EH, Nussenzweig RS & Nussenzweig V. Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. J Exp Med 1983; 157: 19471957.
  • 28
    Mauduit M, Tewari R, Depinay N, et al. Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites. Infect Immun 2010; 78: 21822188.
  • 29
    Culleton R, Martinelli A, Hunt P & Carter R. Linkage group selection: rapid gene discovery in malaria parasites. Genome Res 2005; 15: 9297.